Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cellsDaniel A. Lichtenstein, Nirali N. Shah, Yanyu Wang et al.|Blood|2021Cited by 194
CAR-T cell expansion platforms yield distinct T cell differentiation statesHannah Song, Steven L. Highfill, Michaela Procházková et al.|Cytotherapy|2024Cited by 48
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domainLekha Mikkilineni, James N. Kochenderfer, Danielle Natrakul et al.|Molecular Therapy|2023Cited by 16